CLINICAL_TRIALS
trial_result
· 2013-03-27
Clinical Trial Update: The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study) [Phase 4]
Summary
Phase 4 METS study evaluating metformin for antipsychotic-induced weight gain in schizophrenia; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Mental Health (NIMH) | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-03-27